116 related articles for article (PubMed ID: 2233612)
1. [Immunocytological phenotyping of leukemias and lymphomas. Methods, results, indications and significance].
Schwonzen M; Diehl V; Pfreundschuh M
Med Klin (Munich); 1990 Sep; 85(9):533-47. PubMed ID: 2233612
[No Abstract] [Full Text] [Related]
2. Laboratory practices in reporting flow cytometry phenotyping results for leukemia/lymphoma specimens: results of a survey.
Hassett J; Parker J
Cytometry; 1995 Dec; 22(4):264-81; discussion 330. PubMed ID: 8749777
[TBL] [Abstract][Full Text] [Related]
3. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.
Belov L; Mulligan SP; Barber N; Woolfson A; Scott M; Stoner K; Chrisp JS; Sewell WA; Bradstock KF; Bendall L; Pascovici DS; Thomas M; Erber W; Huang P; Sartor M; Young GA; Wiley JS; Juneja S; Wierda WG; Green AR; Keating MJ; Christopherson RI
Br J Haematol; 2006 Oct; 135(2):184-97. PubMed ID: 16939496
[TBL] [Abstract][Full Text] [Related]
5. [10 years' experiences with flow cytometric immunological phenotyping in malignant hematologic diseases].
Kristensen JS; Hokland P
Ugeskr Laeger; 1996 Oct; 158(43):6098-102. PubMed ID: 8928296
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
7. Immuno-methods in diagnostic hematopathology.
Taylor CR; Parker JW
Methods Achiev Exp Pathol; 1981; 10():37-72. PubMed ID: 7047989
[No Abstract] [Full Text] [Related]
8. Immunophenotyping of leukaemias by flow cytometry and APAAP: a two-year comparative analysis in hospital practice.
Sewell HF; Milton JI; MacKenzie R; King DJ; Dawson AA; Lessels SE; Bennett B; Davidson RL; Walker F
Dis Markers; 1988; 6(4):221-9. PubMed ID: 3069283
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry. Clinical and research applications in hematologic malignancies.
Huh YO; Andreeff M
Hematol Oncol Clin North Am; 1994 Aug; 8(4):703-23. PubMed ID: 7961287
[TBL] [Abstract][Full Text] [Related]
10. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
[No Abstract] [Full Text] [Related]
12. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing.
Deegan MJ
Arch Pathol Lab Med; 1989 Jun; 113(6):606-18. PubMed ID: 2658905
[TBL] [Abstract][Full Text] [Related]
13. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
14. The contribution of immunologic methods to the classification of leukemias and malignant lymphomas.
Plesner T; Wilken M; Avnstrøm S
Clin Lab Med; 1982 Sep; 2(3):579-97. PubMed ID: 6754227
[No Abstract] [Full Text] [Related]
15. Well-differentiated B cell lymphomas/leukaemias express IL-2 receptors identified by immunofluorescence and flow cytometry.
de Paoli P; Santini GF
Clin Exp Immunol; 1987 Apr; 68(1):223-4. PubMed ID: 3115641
[No Abstract] [Full Text] [Related]
16. Flow-cytometric analysis of lymphocytes, leukaemias and lymphomas.
Macey MG
Br J Biomed Sci; 1993 Dec; 50(4):334-49. PubMed ID: 8130695
[TBL] [Abstract][Full Text] [Related]
17. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
18. A practical approach to immunophenotyping of lymphomas. Comparison of immunohistologic and immunocytologic techniques.
Sun T; Susin M
Ann Clin Lab Sci; 1987; 17(1):14-26. PubMed ID: 3555278
[TBL] [Abstract][Full Text] [Related]
19. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
Babusíková O; Glasová M; Stasáková J; Kusenda J; Koníková E
Neoplasma; 1997; 44(6):348-55. PubMed ID: 9605006
[TBL] [Abstract][Full Text] [Related]
20. T-cell receptor expression in lymphoid neoplasms. A comparison of phenotypic expression and genotyping.
Sun T; Henshall J; Cuomo J; Maher K; Rapp D; Goh J
Ann Clin Lab Sci; 1993; 23(6):423-32. PubMed ID: 8291897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
